0 0 -0.00230051412638812 -0.00676906216255427 -0.00423872225893274 -0.00512514706593381 -0.00307831160249483 -0.000257869034763918
Sign Up Today X
Thanks for submitting the form.
Stockreport

Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
of 16.4% during the forecast period (2024-2031). The biosimilars market is expected to grow phenomenally with the expected expiry of important biological patents and an increasing imperative to cut healthcare costs. Opportunities in biosimilars market for entering the market, as patent protection for many blockbusters biologic medicines expire, has taken place in the therapeutic areas of oncology, immunology, and endocrinology. This fact is particularly visible because of the important role of biologics in those cures and maintains areas. Download a detailed overview: https://www.skyquestt.com/sample-request/biosimilars-market Browse in-depth TOC on the " Biosimilars Market " Pages - 165 Tables - 70 Figures – 75 Biosimilars Market Overview: Report Coverage Details Market Revenue in 2023 $27.30 Billion Estimated Value by 2031 $92 Billion Growth Rate Poised to grow at a CAGR of 16.4% Forecast Period 2024–2031 Forecast Units Value (USD Billion) Repor [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
of 16.4% during the forecast period (2024-2031). The biosimilars market is expected to grow phenomenally with the expected expiry of important biological patents and an increasing imperative to cut healthcare costs. Opportunities in biosimilars market for entering the market, as patent protection for many blockbusters biologic medicines expire, has taken place in the therapeutic areas of oncology, immunology, and endocrinology. This fact is particularly visible because of the important role of biologics in those cures and maintains areas. Download a detailed overview: https://www.skyquestt.com/sample-request/biosimilars-market Browse in-depth TOC on the " Biosimilars Market " Pages - 165 Tables - 70 Figures – 75 Biosimilars Market Overview: Report Coverage Details Market Revenue in 2023 $27.30 Billion Estimated Value by 2031 $92 Billion Growth Rate Poised to grow at a CAGR of 16.4% Forecast Period 2024–2031 Forecast Units Value (USD Billion) Repor [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS